1 in 10 patients taking Wegovy and Ozempic lose less than 5 per cent of body weight despite high expectations ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Care Excellence
since
auto-detected in 6 stories
23 days ago
An estimated one in 50 UK adults now use fat jabs with demand soaring since 2023 when the National Institute for Health and Care Excellence (Nice) approved Wegovy for weight loss on the NHS.
3 months ago
Health chiefs advise huge ovarian cancer screening shake-up which could protect thousands of women who are currently excluded from life-saving check-ups ○
found
a story from The Daily Mail 💩 › The Daily Mail
In a draft update to their guidelines, the National Institute for Health and Care Excellence (NICE) has recommended new age-based thresholds for ovarian cancer screening.
8 months ago
Wegovy and Mounjaro patients should be monitored for at least a YEAR after stopping drugs, watchdog says ○
found
a story from The Daily Mail 💩 › The Daily Mail
The National Institute for Health and Care Excellence (Nice) is concerned about the number of people regaining weight after coming off the jabs.
9 months ago
Alzheimer´s drugs rejected for NHS because benefits... ○
found
a story from The Daily Mail 💩 › The Daily Mail
The National Institute for Health and Care Excellence is standing by its earlier decision to turn down donanemab and lecanemab after considering new information.
NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify' ○
found
a story from The Daily Mail 💩 › The Daily Mail
The National Institute for Health and Care Excellence (NICE) has refused the 'miracle' drugs lecanemab and donanemab for use on the NHS as they are too expensive to justify.
10 months ago
Blood cancer patients in England first in world to be offered ‘Trojan horse’ drug ○
found
a story from The Guardian ⚠️ › International
Pioneering drug can halt advance of multiple myeloma for three times as long as standard treatments
Thousands of patients in England with blood cancer will become the first in the world to be offered …
page 1 of 1